Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John S Petersen

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Physical Chemistry Chemical Physics : PCCP|April 8, 2014
2-Colour photolithographyJohn T Fourkas, John S Petersen
Clinical Pharmacokinetics|June 27, 2002
Sevelamer, a phosphate-binding polymer, is a non-absorbed compoundMelissa A Plone, John S Petersen, David P Rosenbaum, et al.
Journal of Pharmaceutical and Biomedical Analysis|June 14, 2002
Determination of the binding parameter constants of Renagel capsules and tablets utilizing the Langmuir approximation at various pH by ion chromatographyRonald A Swearingen, Xi Chen, John S Petersen, et al.
Molecular Cancer Therapeutics|March 26, 2024
Pharmacological Characterization of SDX-7320/Evexomostat: A Novel Methionine Aminopeptidase Type 2 Inhibitor with Anti-tumor and Anti-metastatic ActivityPeter Cornelius, Benjamin A Mayes, John S Petersen, et al.
Frontiers in Oncology|March 6, 2026
Evexomostat (SDX-7320), a methionine aminopeptidase type 2 inhibitor, stimulates weight loss and inhibits obesity-accelerated tumor growthPeter Cornelius, Benjamin A Mayes, Andrew J Dannenberg, et al.
Diabetes, Obesity & Metabolism|June 28, 2023
First-in-human study of a pharmacological duodenal exclusion therapy shows reduced postprandial glucose and insulin and increased bile acid and gut hormone concentrationsMark S Fineman, Christine L N Bryant, Kevin Colbert, et al.
Cancer Research Communications|May 30, 2025
A Phase 1 Safety Study of Evexomostat (SDX-7320) in Patients with Late-Stage Cancer: An Antiangiogenic, Insulin-Sensitizing Drug Conjugate Targeting METAP2Monica M Mita, Alain C Mita, Bradley J Carver, et al.
Iscience|January 10, 2022
Elucidating complex triplet-state dynamics in the model system isopropylthioxanthoneNikolaos Liaros, Sandra A Gutierrez Razo, Matthew D Thum, et al.
ACS Applied Materials & Interfaces|September 5, 2025
Resolving In Situ Exposure Dynamics in a Chemically Amplified EUV Photoresist Using Table-Top EUV Photoemission SpectroscopyDhirendra P Singh, Laura Galleni, Faegheh S Sajjadian, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Physical Chemistry Chemical Physics : PCCP|April 8, 2014
2-Colour photolithographyJohn T Fourkas, John S Petersen
Clinical Pharmacokinetics|June 27, 2002
Sevelamer, a phosphate-binding polymer, is a non-absorbed compoundMelissa A Plone, John S Petersen, David P Rosenbaum, et al.
Journal of Pharmaceutical and Biomedical Analysis|June 14, 2002
Determination of the binding parameter constants of Renagel capsules and tablets utilizing the Langmuir approximation at various pH by ion chromatographyRonald A Swearingen, Xi Chen, John S Petersen, et al.
Molecular Cancer Therapeutics|March 26, 2024
Pharmacological Characterization of SDX-7320/Evexomostat: A Novel Methionine Aminopeptidase Type 2 Inhibitor with Anti-tumor and Anti-metastatic ActivityPeter Cornelius, Benjamin A Mayes, John S Petersen, et al.
Frontiers in Oncology|March 6, 2026
Evexomostat (SDX-7320), a methionine aminopeptidase type 2 inhibitor, stimulates weight loss and inhibits obesity-accelerated tumor growthPeter Cornelius, Benjamin A Mayes, Andrew J Dannenberg, et al.
Diabetes, Obesity & Metabolism|June 28, 2023
First-in-human study of a pharmacological duodenal exclusion therapy shows reduced postprandial glucose and insulin and increased bile acid and gut hormone concentrationsMark S Fineman, Christine L N Bryant, Kevin Colbert, et al.
Cancer Research Communications|May 30, 2025
A Phase 1 Safety Study of Evexomostat (SDX-7320) in Patients with Late-Stage Cancer: An Antiangiogenic, Insulin-Sensitizing Drug Conjugate Targeting METAP2Monica M Mita, Alain C Mita, Bradley J Carver, et al.
Iscience|January 10, 2022
Elucidating complex triplet-state dynamics in the model system isopropylthioxanthoneNikolaos Liaros, Sandra A Gutierrez Razo, Matthew D Thum, et al.
ACS Applied Materials & Interfaces|September 5, 2025
Resolving In Situ Exposure Dynamics in a Chemically Amplified EUV Photoresist Using Table-Top EUV Photoemission SpectroscopyDhirendra P Singh, Laura Galleni, Faegheh S Sajjadian, et al.
Pageof 1